RBC Capital raised the firm’s price target on Cigna to $327 from $300 and keeps a Sector Perform rating on the shares. While the Medicare utilization headwinds pressure peers, Cigna posted an impressive Medical Cost Ratio beat on disciplined commercial risk pricing, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on CI:
- Cigna raises FY23 adjusted EPS view to $24.75 from $24.70, consensus $24.80
- The Cigna Group Reports Strong Third Quarter 2023 Results, Raises 2023 Adjusted EPS, Revenue, and Cash Flow Outlook
- Cigna reports Q3 adjusted EPS $6.77, consensus $6.67
- Notable companies reporting before tomorrow’s open
- CI Earnings this Week: How Will it Perform?